Microvascular Obstruction Diagnosis Using the CoFI™ System Assessment - II
Condition(s) studied
Investigational drug(s) / intervention(s)
CorFlow Controlled Flow Infusion System - CoFI™: The CorFlow CoFI™ System is intended to assess the dynamic microvascular resistance and to treat microvascular obstruction in the coronary vasculature of patients following PCI with stent placement.
Study summary
A prospective, multicenter, international single-arm, pivotal clinical study designed to validate the performance of the CoFI system in detecting MVO in STEMI subjects, as confirmed by CMRI. The study will be conducted in accordance with the Declaration of Helsinki, EN ISO 14155:2020, local and national regulations.
Each study site will receive support from a sponsor-certified proctor during the learning curve to ensure consistent and accurate application of the CoFI system.
Eligibility
Primary outcome measure(s)
- Primary Effectiveness Endpoint — From enrollment to the end of treatment at 6 Months
Diagnostic performance is measured using the two co-primary endpoints, sensitivity and specificity of the CoFI system in detecting MVO in relation to the pre-set pCoFI threshold of 124 mmHg. The analysis will be per-protocol (PP) (primary) and the full analysis set (FAS) (secondary). The control is by LGE CMRI. Hypothesis Both Sensitivity and Specificity will be tested to meet the acceptance criteria: i. The lower bound of the 95% confidence interval (CI) for sensitivity is ≥ 70% ii. The lower bound of the 95% CI for specificity is ≥ 65% These co-primary endpoints are evaluated under a joint hypothesis-testing framework. Primary Safety Endpoint Composite of device- or procedure-related mortality, clinically driven target vessel/lesion revascularization, stent thrombosis and device- or procedure related vessel dissection assessed at 30 days, as adjudicated by the CEC.
Trial sites (25)
| Facility | City | Region | Status |
|---|---|---|---|
| Ronald Reagan UCLA Medical Center | Los Angeles | California | Recruiting |
| ChristianaCare - Christiana Hospital | Newark | Delaware | Recruiting |
| Advocate Good Samaritan Hospital | Downers Grove | Illinois | Not Yet Recruiting |
| Henry Ford Hospital | Detroit | Michigan | Not Yet Recruiting |
| Corewell Health William Beaumont University Hospital | Royal Oak | Michigan | Not Yet Recruiting |
| Trinity Health Ann Arbor Hospital | Ypsilanti | Michigan | Recruiting |
| Allina Health Mercy Hospital | Coon Rapids | Minnesota | Recruiting |
| Allina Health Minneapolis Heart Institute at Abbott Northwestern Hospital | Minneapolis | Minnesota | Recruiting |
| Montefiore Medical Center | The Bronx | New York | Recruiting |
| Atrium Health Carolinas Medical Center | Charlotte | North Carolina | Recruiting |
| The Christ Hospital | Cincinnati | Ohio | Recruiting |
| OhioHealth Riverside Methodist Hospital | Columbus | Ohio | Recruiting |
| WVU Medicine - J.W. Ruby Memorial Hospital | Morgantown | West Virginia | Recruiting |
| Aurora St. Luke's Medical Center | Milwaukee | Wisconsin | Recruiting |
| University Hospital of Ferrara - Sant'Anna Hospital | Ferrara | Italy | Not Yet Recruiting |
| Humanitas Research Hospital | Milan | Italy | Not Yet Recruiting |
| Monzino Cardiology Center | Milan | Italy | Not Yet Recruiting |
| Umberto I University Hospital - Sapienza University of Rome | Rome | Italy | Not Yet Recruiting |
| City of Health and Science University Hospital of Turin - Molinette Hospital | Turin | Italy | Not Yet Recruiting |
| Integrated University Hospital of Verona - Borgo Trento Hospital | Verona | Italy | Not Yet Recruiting |
| The Hospital of Lithuanian University of Health Sciences (LSMU) Kauno klinikos | Kaunas | Lithuania | Recruiting |
| Vilnius University Hospital Santariskiu Klinikos | Vilnius | Lithuania | Recruiting |
| Dedinje Institute for Cardiovascular Diseases | Belgrade | Serbia | Not Yet Recruiting |
| Valjevo General Hospital | Valjevo | Serbia | Not Yet Recruiting |
| Cardiocentro Ticino | Lugano | Canton Ticino | Recruiting |
Other trials for the same condition
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
View NCT06909578 on ClinicalTrials.gov ↗ ← All trials in the USA